Creating a blood test for herpes simplex viruses 1 and 2.
Official title: SBIR Topic 133: Development of a Serological Test for Herpes Simplex Types 1 and 2 Infections
Funded at Qoolabs, INC. · NIH-11203294 · Data updated 2026-11-12
This study is working on a new blood test to help people find out if they have been infected with the herpes virus, so they can get better care and make more informed health choices.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Qoolabs, INC. NIH-funded |
| Lab location | 1 site (Carlsbad, UNITED STATES) |
| Project start | September 10, 2024 |
| Project end | September 9, 2025 |
| Funding year | 2024 |
| Award (this year) | $300,000 |
| NIH project number | 75N93024C00046-0-9999-1 |
| Project ID | NIH-11203294 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals who are at risk of or suspect they may have herpes simplex virus infections.
✕Less likely to help
Patients who have already been diagnosed and are receiving effective treatment for herpes simplex viruses may not benefit from this research.
What this research studies
This research focuses on developing a serological test to detect infections caused by Herpes Simplex Virus types 1 and 2. The approach involves creating a diagnostic tool that can identify antibodies in the blood, which indicates whether a person has been infected with these viruses. By improving the accuracy and availability of testing, this research aims to enhance the management and treatment of herpes infections. Patients may benefit from more reliable testing options that can lead to better-informed healthcare decisions.
Why it matters
Potential benefit: If successful, this research could provide patients with a more accurate and accessible way to diagnose herpes simplex virus infections.
How similar studies have gone: Other research has shown success in developing serological tests for viral infections, indicating that this approach has potential.
Where this research is happening
-
Qoolabs, INC.
Carlsbad, United States Active
Researchers
- Principal investigator: Qi, Hong — Qoolabs, INC.
- Study coordinator: Qi, Hong
Related research
Other NIH-funded projects on the same topics.
-
Developing quick tests for Hepatitis C detection.
This study is working on a quick and easy test for Hepatitis C that can be done right where you receive care, making it simpler for people to get tested and start treatment faster.
-
Creating antibodies to study long-COVID in hamsters
This study is looking to create special antibodies that can help researchers learn more about how the immune system responds to long-COVID in hamsters, which could eventually help us understand the condition better for everyone.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.